Reviva Pharmaceuticals Holdings RVPH
OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Reviva Pharmaceuticals Holdings (RVPH) Cash & Current Investments (2018 - 2026)

Updated

Reviva Pharmaceuticals Holdings (RVPH) posted Cash & Current Investments of $19.89 million for Q2 2026, up 91.9% from $10.36 million a year earlier but down 10.4% from the prior quarter.

Analysis

Reviva Pharmaceuticals Holdings (RVPH) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Reviva Pharmaceuticals Holdings' Cash & Current Investments came in at $14.44 million, up 7.1% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
  • In prior years, Reviva Pharmaceuticals Holdings' Cash & Current Investments was $13.48 million in FY2024 (-42.3%), $23.37 million in FY2023 (+26.2%) and $18.52 million in FY2022.
  • Quarterly Cash & Current Investments has run from a low of $4.97 million in Q3 2023 to a high of $33.49 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments has increased in each of the last five quarters, with growth averaging 67.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2026, with growth of 319.5%; the weakest was Q3 2023, with a decline of 78.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $22.19 million (Q1 2026), $14.44 million (Q4 2025) and $13.18 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn 17.23 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn 10.77 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - 505.00 Mn
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn 8.17 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn 6.44 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn 14.27 Bn
10 Reviva Pharmaceuticals Holdings 4.46 Mn -82.75 Mn - 17.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 17.46 Mn
Jun 30, 2026 19.89 Mn
Mar 31, 2026 22.19 Mn
Dec 31, 2025 27.67 Mn
Sep 30, 2025 25.10 Mn
Jun 30, 2025 19.39 Mn
Mar 31, 2025 9.15 Mn
Dec 31, 2024 25.68 Mn
Sep 30, 2024 9.75 Mn
Jun 30, 2024 11.11 Mn
Mar 31, 2024 11.97 Mn
Dec 31, 2023 23.37 Mn
Sep 30, 2023 4.97 Mn
Jun 30, 2023 11.15 Mn
Mar 31, 2023 11.26 Mn
Dec 31, 2022 18.52 Mn
Sep 30, 2022 23.19 Mn
Jun 30, 2022 19.42 Mn
Mar 31, 2022 23.42 Mn
Dec 31, 2021 29.69 Mn
API Access

Reviva Pharmaceuticals Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RVPH&period=max&api_key=YOUR_API_KEY